Oral cancer, also known as mouth cancer, is cancer of the lining of the lips, mouth, or upper throat. In the mouth, it most commonly starts as a painless white patch, that thickens, develops red patches, an ulcer, and continues to grow.
This report contains market size and forecasts of Mouth Cancer Treatment in Global, including the following market information:
Global Mouth Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mouth Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mouth Cancer Treatment include Bristol-Myers Squibb, Qilu Pharmaceutical, Teva Pharmaceutical Industries, Eli Lilly And Company, Roche, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mouth Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mouth Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mouth Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Radiotherapy
Chemotherapy
Others
Global Mouth Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mouth Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Research Centers
Others
Global Mouth Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mouth Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mouth Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mouth Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Qilu Pharmaceutical
Teva Pharmaceutical Industries
Eli Lilly And Company
Roche
Merck
Novartis
Pfizer